| Nov 4 |
BMRN vs. INCY: Which Stock Is the Better Value Option?
|
| Nov 1 |
Beyond the Balance Sheet: What SWOT Reveals About Biomarin Pharmaceutical Inc (BMRN)
|
| Oct 31 |
BioMarin price target raised to $106 from $104 at UBS
|
| Oct 31 |
BioMarin Pharmaceutical Third Quarter 2024 Earnings: Beats Expectations
|
| Oct 30 |
BioMarin downgraded at William Blair following narrowing of revenue guidance
|
| Oct 30 |
Q3 2024 BioMarin Pharmaceutical Inc Earnings Call
|
| Oct 30 |
BioMarin Q3 Earnings & Revenues Beat Estimates, '24 Guidance Raised
|
| Oct 30 |
Biomarin Pharmaceutical Inc (BMRN) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...
|
| Oct 30 |
BioMarin Pharmaceutical Inc. (BMRN) Q3 2024 Earnings Call Transcript
|
| Oct 29 |
BioMarin (BMRN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
|
